Oximes: Novel therapeutics with anticancer and anti-inflammatory potential

IA Schepetkin, MB Plotnikov, AI Khlebnikov… - Biomolecules, 2021 - mdpi.com
Oximes have been studied for decades because of their significant roles as
acetylcholinesterase reactivators. Over the last twenty years, a large number of oximes have …

Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship

H Wang, Z Wang, C Wei, J Wang, Y Xu, G Bai… - European Journal of …, 2021 - Elsevier
Indirubin is the crucial ingredient of Danggui Longhui Wan and Qing-Dai, traditional
Chinese medicine herbal formulas used for the therapy of chronic myelocytic leukemia in …

Roscovitine-derived, dual-specificity inhibitors of cyclin-dependent kinases and casein kinases 1

N Oumata, K Bettayeb, Y Ferandin… - Journal of medicinal …, 2008 - ACS Publications
Cyclin-dependent kinases (CDKs) and casein kinases 1 (CK1) are involved in the two key
molecular features of Alzheimer's disease, production of amyloid-β peptides (extracellular …

Understanding kinase selectivity through energetic analysis of binding site waters

DD Robinson, W Sherman… - … : Chemistry Enabling Drug …, 2010 - Wiley Online Library
Kinases remain an important drug target class within the pharmaceutical industry; however,
the rational design of kinase inhibitors is plagued by the complexity of gaining selectivity for …

Indirubin derivatives as dual inhibitors targeting cyclin-dependent kinase and histone deacetylase for treating cancer

Z Cao, F Yang, J Wang, Z Gu, S Lin… - Journal of medicinal …, 2021 - ACS Publications
To utilize the unique scaffold of a natural product indirubin, we herein adopted the strategy
of combined pharmacophores to design and synthesize a series of novel indirubin …

A class of 2, 4-bisanilinopyrimidine Aurora A inhibitors with unusually high selectivity against Aurora B

I Aliagas-Martin, D Burdick, L Corson… - Journal of medicinal …, 2009 - ACS Publications
The two major Aurora kinases carry out critical functions at distinct mitotic stages. Selective
inhibitors of these kinases, as well as pan-Aurora inhibitors, show antitumor efficacy and are …

Soluble 3′, 6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase-3 alter circadian period

K Vougogiannopoulou, Y Ferandin… - Journal of medicinal …, 2008 - ACS Publications
Glycogen synthase kinase-3 (GSK-3) is a key enzyme involved in numerous physiological
events and in major diseases, such as Alzheimer's disease, diabetes, and cardiac …

5, 5′-substituted indirubin-3′-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity

SJ Choi, JE Lee, SY Jeong, I Im, SD Lee… - Journal of medicinal …, 2010 - ACS Publications
To enhance the ability of indirubin derivatives to inhibit CDK2/cyclin E, a target of anticancer
agents, we designed and synthesized a new series of indirubin-3′-oxime derivatives with …

Updating dual-specificity tyrosine-phosphorylation-regulated kinase 2 (DYRK2): molecular basis, functions and role in diseases

A Correa-Sáez, R Jiménez-Izquierdo… - Cellular and Molecular …, 2020 - Springer
Members of the dual-specificity tyrosine-regulated kinase (DYRKs) subfamily possess a
distinctive capacity to phosphorylate tyrosine, serine, and threonine residues. Among the …

[HTML][HTML] Thieno [2, 3-d] pyrimidine based derivatives as kinase inhibitors and anticancer agents

EZ Elrazaz, RAT Serya, NSM Ismail… - Future Journal of …, 2015 - Elsevier
Thienopyrimidines are fused heterocyclic ring systems; structurally resemble purines,
exerting pharmacological potential in different aspects. They are known to play a crucial role …